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INTRODUCTION 58
Vitamin D-binding protein (DBP), a 52-59 kDa protein also known as group-specific 59 component of serum (GC-globulin), is the primary plasma carrier for circulating vitamin D 60 and its metabolites (White and Cooke, 2000) . Expression of GC/Gc, which encodes DBP, is 61
highly-expressed in the liver of all mammals (Feldman et al., 2017) , in keeping with the 62 function of this organ to convert sterol-derivatives such as cholecalciferol (Vitamin D 3 ) into 63
pre-hormone 25-OH vitamin D (25(OH)D) (Bikle, 2014) . DBP is also expressed in the 64 pancreatic islets. Recent studies have shown that GC/Gc is highly-expressed in purified 65 mouse and human α-cells ( the role of DBP in the regulation of glucagon release, and in wider aspects of islet function, 71
remains enigmatic. 72
Evidence that the effects of DBP in α-cells are unrelated to serum vitamin D transport 73 comes from studies in vitamin D-deficient patients who show no improvement in insulin-74
induced glucagon output upon vitamin D repletion (Gedik and Akalin, 1986) . Moreover, a 75 patient harboring a rare mutation in GC showed no symptoms of vitamin D deficiency, 76
despite low plasma levels of 25(OH)D, arguing that it is the free form of 25(OH)D that 77 dictates many of the non-classical actions of vitamin D (Chun et al., 2014; Henderson et al., 78 2019). Alongside its role in 25(OH)D transport, DBP is also a major actin scavenger (Harper 79 et al., 1987) . Following disassembly of polymerized actin by gelsolin, DBP traps monomeric 80 filaments using its three domains as a clamp (Otterbein et al., 2002) . Pertinently, ephrin-A 81 forward signaling has been shown to inhibit glucagon secretion through increases in F-actin 82 density (Hutchens and Piston, 2015) , and the appearance of regulated glucagon secretion in 83 re-aggregated islets coincides with normalization of F-actin levels (Reissaus and Piston, 84 2017). 85
Linking DBP with type 2 diabetes (T2D) risk, GC variants are associated with 86 elevated fasting glucose, fasting insulin levels and responses to oral glucose tolerance (Baier 87 et al., 1998; Hirai et al., 2000; Iyengar et al., 1989; Szathmary, 1987) . Results, however, 88 tend to be conflicting, likely reflecting heterogeneity introduced by ethnicity and environment 89 (Malik et al., 2013; Wang et al., 2014) . The concept that DBP might also be involved in type 90 1 diabetes (T1D) risk is supported by retrospective cross-sectional analysis of 472 91
individuals showing that serum DBP levels were lowest in patients with T1D (Blanton et al., 92 2011). Using gene expression-based genome-wide association studies, DBP was 93 subsequently identified as a novel T1D autoantigen (Kodama et al., 2016) . The same 94
authors showed that T-cell reactivity against DBP was increased in NOD mice, and that 95 humans with T1D possess specific DBP autoantibodies (Kodama et al., 2016) . Together, 96
these studies suggest that DBP is likely to be associated with altered diabetes risk in 97
humans. 98
Here, we sought to establish the role of DBP in α-cell phenotype, function and 99
diabetes risk by combining studies in knockout mice with staining of pancreata from T1D 100 donors and age-matched controls. We show that DBP is critical for proper α-cell function and 101 glucagon secretion, with related effects for δ-cell morphology and insulin release. We further 102
show that glucagon and DBP expression decrease in α-cells of individuals with late-onset or 103 longstanding T1D, but not in children with early-onset disease. As such, DBP should be 104 considered as an essential component of the α-cell and the wider islet functional machinery 105
with relevance for glucagon secretion during diabetes. 106 RESULTS 108
DBP is deleted in α-cells of DBP -/mice 109
Confocal imaging showed an intense DBP signal localized predominantly to GLU+ cells at 110 the islet periphery in mice ( Figure 1A ). While DBP expression was clearly decreased in DBP -111 /animals, a faint signal could still be detected in some α-cells using fluorescent 112 immunohistochemistry ( Figure 1A ). This likely reflects the sensitivity of the staining protocol 113 used since non-fluorescent immunohistochemistry implied complete loss of DBP in DBP -/-114 islets ( Figure 1B) . We wondered whether DBP was also expressed in other islet cell types, 115 but might be obscured by the strong staining detected in α-cells. Therefore, immunostaining 116 was repeated using a higher antibody concentration combined with more sensitive imaging 117 settings to oversaturate signal in α-cells but not in other cells. Using this approach, weak 118 DBP expression could be detected in the β-cell compartment, which was absent in islets 119 from DBP -/mice ( Figure 1C ). 120
Gc was undetectable using specific Taqman assays ( Figure 1D ), and circulating 25(OH)D 121
and hormonal 1,25-(OH) 2 vitamin D (1,25(OH) 2 D) levels were ~50% decreased in 122
heterozygous DBP +/mice, and virtually undetectable in homozygous DBP -/littermates 123
( Figure 1E and 1F). Despite low levels of 25(OH)D and 1,25(OH) 2 D, DBP -/animals do not 124
show signs of vitamin D deficiency unless placed on a vitamin D-deficient diet (Safadi et al., 125 1999) . 126
Metabolic phenotyping of DBP -/mice at 8-12 weeks revealed normal glucose tolerance 127
( Figure 1G and H), insulin sensitivity ( Figure 1I and 1J) and pyruvate tolerance versus 128 littermate controls ( Figure 1K ). Growth curves and adult body weight were similar between 129 genotypes ( Figure 1L ). Thus DBP -/mice possess an apparently normal metabolic 130 phenotype, without changes in insulin sensitivity or hepatic gluconeogenesis that could non-131
autonomously influence α-cell mass/function. With this in mind, we proceeded to conduct the 132 remainder of the studies in isolated pancreata and islets. 133
Deletion of DBP leads to abnormal islet morphology 134
Cell resolution immunostaining of entire pancreatic sections showed no changes in α-cell or 135 β-cell mass following loss of DBP (Figure 2A and B). While detailed morphometric analyses 136 of individual DBP -/islets revealed an increase in α-cell number ( Figure 2C and D) (also 137 apparent in Figure 1A ), this was accompanied by a decrease in α-cell size ( Figure 2E ), 138 maintaining the area occupied by α-cells ( Figure 2F ). Although a small but significant 139 increase in β-cell number was apparent ( Figure 2G ), no changes in β-cell size ( Figure 2H ) or 140 area occupied by β-cells ( Figure 2I ) were detected between DBP -/and DBP +/+ animals. 141
However, a ~2-fold decrease in δ-cell mass was detected ( Figure 2J and 2K), along with a 142 reduction in the size of individual δ-cells ( Figure 2L and 2M). 143
Suggesting that loss of DBP is not associated with α-cell de-differentiation, mRNA levels for 144
Pax6, Arx and Pou3f4 was similar in islets from DBP +/+ and DBP -/mice ( Figure 2N ). No 145 differences in the number of (very rare) cells co-staining for GLU/PDX1 or GLU/MAFA were 146 detected ( Figure 2O -Q), implying that adoption of a β-cellor δ-cell-like fate by α-cells was 147 unlikely. Moreover, a similar number of PCNA+ or proliferative α-cells was detected in DBP -/-148 and DBP +/+ animals, suggesting normal cell turnover rates ( Figure S1 ). While DBP was 149 expressed in some but not all δ-cells ( Figure 2R ), expression of the δ-cell differentiation 150
markers Hhex and Ghsr was unchanged in DBP -/islets ( Figure 2S ). 151
Thus, DBP -/islets are morphologically abnormal, containing smaller and more abundant α-152 cells alongside a modest contraction of the δ-cell compartment. 153
DBP is critical for α-cell, δ-cell and β-cell function 154
Multicellular Ca 2+ imaging of DBP -/islets showed large impairments in the activity of α-cells, 155
identified by their responses to low glucose and epinephrine ( Figure 3A -C) (Tian et al., 156 2011) . This presented as a loss of α-cell activation by low glucose ( Figure 3A ), although 157 some α-cells that remained active displayed characteristic Ca 2+ -spiking responses of 158 elevated amplitude ( Figure 3B and 3C). We also examined the ability of α-cells to coordinate 159
Ca 2+ responses within clusters throughout the imaged plane. Unexpectedly, α-cell population 160 activity in DBP -/mice was more stochastic, with an almost 2-fold decrease in coordinated α-161
cell-α-cell activity ( Figure 3D ). This was not dependent on loss of a specific subset of α-cells, 162 since topology of the communicating α-cells was unaffected by DBP loss ( Figure 3E ). 163
The same islets were also examined for changes in β-cell activity at both low (0.5 mM) and 164
high (17 mM) glucose. A large increase in the proportion of β-cells active at low glucose was 165 observed ( Figure 3F ), identified on the basis of their responsiveness to subsequent 166 challenge with high glucose. However, no differences in β-cell activity were detected at high 167 glucose ( Figure 3G and 3H ), suggesting the presence of intact glucose metabolism. 168
To record δ-cell activity, islets were imaged at 5 mM glucose before increasing concentration 169
of the sugar to 17 mM. δ-cells were identified by their characteristic, rare, Ca 2+ -spiking 170 patterns at 5 mM glucose ( Figure 3K ), which did not change in the presence of high glucose 171
(compared to β-cells) (Shuai et al., 2016; Vierra et al., 2018) . Suggesting the presence of 172 abnormal function, the proportion of active δ-cells was increased in DBP -/islets (Figure 3I  173 and 3J), possibly reflecting compensation for reduced δ-cell number. However, δ-cells that 174 did respond displayed Ca 2+ spikes of normal amplitude ( Figure 3K ). 175 DBP is required for normal α-cell Na + channel conductance 176 α-cells generate electrical activity, with Na + channel inactivation properties playing an 177 important role in determining glucagon secretion (Zhang et al., 2013) . Using patch clamp 178 electrophysiology, we therefore explored whether DBP influences α-cell Na + channel 179 function. As expected from the increased Ca 2+ amplitude detected in these cells, Na + 180 currents were increased in α-cells lacking DBP ( Figure 3L ). However, the slope factor of Na + 181
inactivation also tended to be increased ( Figure 3M and N), despite a similar half maximal 182 voltage ( Figure 3O ), suggesting the presence of impairments in glucose-dependent α-cell 183 activity. 184
We further subjected patch-clamp recordings from DBP +/+ and DBP -/islets to a 185 mathematical model (Briant et al., 2017b) . This model takes as input the electrophysiological 186
data of a cell, and outputs a probability that the cell is an α-cell. While the model predicted 187
α-cell phenotype in DBP +/+ islets with high probability, confidence was lower in recordings 188 from DBP -/islets with the output favoring a more δ-cell-like (probability = 0.27 versus 0.48, 189 DBP +/+ versus DBP -/-, respectively, P<0.05), but not β-cell-like (probability = 4.43 x 10 -7 190 versus 1.15 x 10 -8 , DBP +/+ versus DBP -/-, respectively, non-significant) profile ( Figure 3P ). 191
Thus, α-cells lose their "electrophysiological identity", become less α-cell-like, and resemble 192 δ-cells following loss of DBP. Confirming the decrease in α-cell size detected using 193 immunohistochemistry, membrane capacitance was significantly lower in cells predicted to 194 be α-cells in DBP -/islets ( Figure 3Q ). 195
DBP regulates glucagon and insulin secretion 196
DBP +/+ islets responded to low (0.5mM) glucose with a 2-fold increase in glucagon secretion 197
( Figure 3R ). By contrast, DBP -/islets showed a tendency toward increased basal glucagon 198 levels and loss of glucagon secretion in response to low glucose ( Figure 3R ). Glucagon 199 secretory responses to epinephrine were also significantly impaired in DBP -/islets, pointing 200 toward a defect in exocytosis ( Figure 3R ). Suggesting the presence of normal glucagon 201 biosynthesis, total levels of the hormone were similar between DBP +/+ and DBP -/littermates 202
( Figure 3S ). 203
Conversely to glucagon, glucose-stimulated insulin secretion was significantly increased in 204
islets from DBP -/animals ( Figure 3T ). This effect was likely associated with improved 205 exocytosis of the readily-releasable pool of insulin granules, since KCl-stimulated insulin 206
secretion was similarly increased in DBP -/versus DBP +/+ islets ( Figure 3T ), despite 207 equivalent insulin content ( Figure 3U ). 208
Thus, DBP is required for normal glucose-regulated glucagon secretion, and limits insulin 209 secretion under high glucose stimulation. 210
DBP mediates α-cell function through F-actin binding 211
DBP is a major actin scavenger and might exert effects on α-cell size and glucagon 212 secretion by trapping monomeric actin (G-actin), which is needed to form polymerized actin 213 (F-actin) (Dominguez and Holmes, 2011). To investigate DBP-actin interactions, high 214 resolution snapshots were taken of islets stained with either phalloidin or DNAaseI to 215 demarcate F-actin and G-actin, respectively. While F-actin density was unchanged in DBP -/-216 islets, increases in intensity and fiber thickness were seen throughout the islet ( Figure 4A -217 C), rather than restricted solely to α-cells. Conversely, G-actin levels tended to be reduced in 218 DBP -/mice, again being evident throughout the islet ( Figure 4D and E). 219
Since F-actin/G-actin ratio is important for regulated secretion (Kalwat and Thurmond, 220 2013), glucagon granule size and distribution were mapped in pancreatic slices using super-221 resolution imaging. Analysis of individual granules revealed a small but significant decrease 222 in granule size in DBP -/mice, although area occupied was unchanged, pointing to an 223 increase in granule number ( Figure 4F and G). While glucagon granules tended to be 224 clustered in DBP +/+ α-cells, they were more diffusely scattered throughout the cytoplasm in 225 DBP -/tissue ( Figure 4H and I). 226
Lastly, we investigated whether normal activity could be restored in DBP -/islets by reducing 227 F-actin levels to DBP +/+ levels. Experiments were performed in the absence or presence of 228
Latrunculin B, which prevents F-actin polymerization (Spector et al., 1983) . A concentration-229
response showed that Latrunculin B was able to modulate F-actin within the range detected 230
in DBP +/+ islets ( Figure 4J ). Notably, using 300 nM Latrunculin B to reduce F-actin in DBP -/-231 islets down to DBP +/+ levels ( Figure 4K ), we were able to restore α-cell Ca 2+ responses to 232 low glucose ( Figure 4L and M). 233
Together, these results suggest that DBP increases availability of monomeric G-actin, which 234
is then able to polymerize to form F-actin, ultimately altering granule distribution and size, as 235
well as α-cell function. 236
DBP and glucagon expression are decreased in late-onset and longstanding T1D 237 donors 238
Islet α-cells persist in T1D, but display reduced glucose responsiveness (Brissova et al., 239 2018; Gerich et al., 1973) , which could be associated with changes in DBP expression. We 240 therefore examined whether DBP levels changed in T1D, initially using pancreatic sections 241 from the Exeter Archival Diabetes Biobank. Immunohistochemistry was performed on 242 sections from donors with early-and late-onset T1D, together with their age-matched 243 controls. In donors without diabetes, DBP was highly localized to α-cells ( Figure 5A ), as 244 previously shown (Kodama et al., 2016; Lam et al., 2019), although we were also able to 245 detect very faint expression in β-cells, as for mouse ( Figure S3 ). In sections from donors 246 with T1D, a similar pattern of DBP immunostaining was observed ( Figure 5B ). While a small 247 but significant decrease in glucagon expression was seen in islets of early-onset T1D donors 248
( Figure 5C ), this was not accompanied by changes in DBP staining ( Figure 5D ) or proportion 249 of α-cells immunopositive for DBP ( Figure 5E ). 250
By contrast, glucagon levels were almost 2-fold lower in islets of late-onset T1D donors 251 versus age-matched controls ( Figure 5F and G), in line with previous reports of decreased α-252 cell mass during T1D (von Herrath et al., 2018). These changes were accompanied by a 253 reduction in DBP expression ( Figure 5H ) and α-cell size ( Figure 5I ), although no differences 254
were detected in the number of DBP+/GLU+ cells per islet ( Figure 5J ). We were able to 255 confirm results in samples from IsletCore (Alberta), and also show that DBP levels 256
consistently decrease in islets of donors with more longstanding T1D ( Figure S3 ). 257
Immunohistochemistry of control islets showed that DBP expression increased with age, 258
peaking at 18-32 years and remaining elevated thereafter ( Figure 6A and B). Similar results 259
were seen for glucagon expression ( Figure 6C ). Glucagon and DBP expression values for 260 each individual donor are provided in Figure S4 . 261
Granular DBP content decreases in late-onset T1D 262
Analysis of a published RNA-seq dataset (Brissova et al., 2018) revealed no differences in 263
GC expression in purified α-cells from control and T1D donors (20 to 53 years) ( Figure 6D ), 264
suggesting that DBP might be post-transcriptionally regulated. As such, we investigated 265 DBP and glucagon localization within human α-cells using super-resolution microscopy. 266
Unexpectedly, DBP was found to be present in glucagon granules of control donors ( Figure  267 6E), suggesting that DBP enters the secretory pathway and might function in an autocrine 268 manner. Explaining the decrease in glucagon and DBP expression in late-onset T1D 269
samples, a large reduction in the number of GLU+/DBP+ granules was detected in each α-270 cell ( Figure 6F ), accompanied by a small decrease in DBP/GLU co-localization ( Figure 6G ).
271
Glucagon granules were also smaller and more randomly distributed in late-onset T1D α-272 cells ( Figure 6H and I), suggestive of changes in the actin cytoskeleton, as demonstrated for 273 mice. 274
DISCUSSION 276
In the present study, we show that DBP is strongly expressed in murine and human α-cells.
277
Loss of DBP leads to alterations in α-cell number and size, electrical activity and glucagon 278
release. This is accompanied by changes in δ-cell mass, as well as alterations in β-cell 279 function and insulin release. Linking these findings, DBP was found to decrease the 280 availability of actin monomeric subunits for assembly into polymers. DBP expression levels 281
were also decreased in islets of donors with late-onset or longstanding T1D, but not in 282 children with early-onset disease. 283
Transcriptomic studies have consistently shown that Gc is highly-enriched in the with these findings, our immunohistochemical analyses confirmed that DBP is predominantly 287 expressed at the protein level in α-cells in both mouse and human. Careful inspection of 288 images also detected faint DBP expression in β-cells, which was difficult to appreciate due to 289 the high intensity of the DBP signal in α-cells. Notably, DBP expression was also absent in 290 β-cells in DBP -/islets, and F-actin and G-actin were both altered across the islet. Thus, DBP 291
is detectable in both α-cells and β-cells, with large differences in expression levels apparent 292 between the two compartments. In addition, recent studies have shown that β-cells increase 293
histone modification at the Gc locus in response to high fat feeding, with knockout of Gc 294
protecting from β-cell dysfunction (Kuo et al., 2019) . Thus, DBP protein expression in the β-295 cell compartment is low, but is likely to be upregulated under conditions of metabolic stress. 296
Intriguingly, Na + currents, which contribute to action potential firing in α-cells, were 297 increased in DBP -/α-cells. This was mirrored at the level of low glucose-stimulated Ca 2+ 298
rises, which were also increased by loss of DBP. Given that α-cell function was otherwise 299 decreased across the board (i.e. defective glucagon secretion, activation by low glucose, 300 electrophysiological identity, Na + channel inactivation), increases in Na + conductance and 301
Ca 2+ spiking amplitude are likely to reflect a maladaptive compensatory response. 302
Supporting the notion that F-actin is an important regulator of glucagon release 303 (Hutchens and Piston, 2015), fiber size was increased in DBP -/animals, alongside 304 decreases in monomeric G-actin content. Thus, DBP in the α-cell likely scavenges G-actin, 305
preventing formation of F-actin polymers, which would otherwise suppress glucagon release.
306
At the molecular level, F-actin has been shown to restrict basal insulin release (Kalwat and 307
Thurmond, 2013), as well as maximal glucagon secretion, by acting as a physical constraint 308 against granule exocytosis (Hutchens and Piston, 2015; Reissaus and Piston, 2017). 309
Morphological evidence for this was provided in the current study by the observation that 310
glucagon granules were distributed more diffusely in DBP -/islets. Furthermore, granule size 311 was decreased, indicative of either preferential sequestration of immature granules, or 312 effects of DBP on granule maturity. Cytoskeletal changes were also likely to be involved in 313 the reduction in α-cell and δ-cell size, since assembly of actin filaments from monomers is 314 critical for cell morphology (Pollard and Cooper, 2009) . 315 β-cells displayed increased Ca 2+ activity at low glucose in DBP -/islets. This however 316 did not translate to elevated basal insulin release, probably because F-actin fiber thickness 317
was also increased across β-cells, potentially acting as a barrier for unregulated granule 318
exocytosis (Mziaut et al., 2016) . While DBP levels were much lower in β-cells compared to 319 α-cells, it could be argued that only small amounts are required to prevent actin 320 polymerization given the high binding affinity for monomeric actin (Mc Leod et al., 1989) . By 321 contrast, the increase in glucose-stimulated insulin secretion seen in DBP -/islets is most 322 likely due to lack of α-cell shut-off at high glucose, expected to positively reinforce β-cell 323
function (Svendsen et al., 2018) . Indeed, electrophysiological recordings showed that the 324 Na + channel inactivation switch tended to be impaired in DBP -/α-cells. An alternative 325 mechanism might center on changes in glucose-stimulated actin remodelling in the β-cells 326 themselves, for example by gelsolin (Tomas, 2006) , which severs actin filaments but in 327 competition with DBP. 328
Demonstrating the relevance of our studies for human disease, islets in pancreata 329
from individuals with late-onset or longstanding T1D consistently showed decreased DBP 330 expression, as well as a reduction in α-cell size. Super-resolution imaging showed that the 331 majority of glucagon granules in human α-cells also contained DBP, with a sharp decrease 332 in granular expression levels during T1D. A similar localization of DBP to secretory granules 333 was reported in human neutrophils, together with release of the protein into the extracellular 334 milieu (Kew et al., 1993) . Since the GC transcriptional machinery is present in the α-cell, the 335 source of this DBP is likely from de novo synthesis. It is also plausible that DBP is 336 transported from the circulation into α-cells by megalin-mediated endocytosis, as reported in 337 the kidney (Nykjaer et al., 1999) , and that either this process, or liver production of DBP, is 338 altered during T1D. However, it is difficult to envisage how endocytosis would lead to 339 accumulation of DBP specifically in glucagon granules. 340
Interestingly, no changes in DBP expression were found in early-onset T1D donors. 341
While the exact reasons for this are unknown, DBP was significantly lower in young versus 342 old control donors without T1D. These data suggest that DBP expression and thus α-cell 343 identity might not be fully specified until adolescence, meaning that DBP cannot be further 344 downregulated in early-onset T1D. These data raise a number of interesting questions 345
involving the known role of DBP as a novel autoantigen during T1D ( morphometric analyses were based upon glucagon staining, which could lead to an 371
underestimation of α-cell size in T1D samples, especially if the fewer detectable granules 372
were not distributed evenly throughout the cytoplasm. Fourthly, although mice did not show 373 a clear phenotype, further studies are warranted using in vivo models of α-cell stress, for 374 example glucagon receptor antagonism to induce hyperplasia (Gu et al., 2009 ). Lastly, while 375 a causal role for DBP in α-cell dysfunction is suggested by mouse studies, we cannot 376 confidently assert the same in islets of human T1D donors where autoimmunity and species-377
differences come into play. 378
In summary, we show that DBP is critical for maintaining α-cell phenotype and 379 glucagon secretion, with changes in expression apparent during late-onset and longstanding 380
T1D. The stage is now set for investigating more widely how DBP influences islet function 381
and disease risk in individuals with T1D and T2D. 382
STAR METHODS 383

KEY RESOURCES TABLE 384
CONTACT FOR REAGENT AND RESOURCE SHARING 385
Further information and requests for resources and reagents should be directed to and will 386 be fulfilled by the Lead Contact, David J. Hodson (d.hodson@bham.ac.uk). 387
STUDY DESIGN 388
No data were excluded unless the cells displayed a clear non-physiological state (i.e. 389
impaired viability), and all individual data points are reported in the figures. The 390 measurement unit is animal, batch of islets or donor, with experiments replicated 391
independently at least three times. Samples and animals were allocated to treatment groups 392 in a randomized manner to ensure that all states were represented in the different 393 experiment arms. Investigators were blinded to animal and donor identity both during the 394 experiment and subsequent analysis. 395
EXPERIMENTAL MODEL AND SUBJECT DETAILS 396
Mouse models 397
DBP -/mice were generated using a PGK-promoter/neomycin cassette to disrupt exon 5 of 398
the mouse Gc gene, as described (Safadi et al., 1999) . We used these animals rather than 399
the KOMP repository strain (Gctm1 (KOMP)Vlcg ; VG11723), since they have been subjected to 
Human donors 407
Formalin-fixed paraffin-embedded pancreata were obtained from the Exeter Archival 408
Diabetes Biobank (http://foulis.vub.ac.be/) or the Alberta Diabetes Institute IsletCore (quality 409 control and phenotyping data is available for each preparation (via www.isletcore.ca and 410
iidp.coh.org). Studies with human tissue were approved by the University of Birmingham 411
Ethics Committee, as well as the National Research Ethics Committee (REC reference 412 16/NE/0107, Newcastle and North Tyneside, U.K.). Donor characteristics are reported in 413  Table S1 . 414
METHOD DETAILS 415
Islet isolation and culture 416
Animals were euthanized by a cervical dislocation, before isolation of islets using 417 collagenase digestion (1 mg/ml, SERVA NB8; amsbio Cat# 17456.01) and Histopaque or 418
Ficoll-Paque gradient separation. Islets were maintained at 37°C and 5% CO 2 in RPMI 419 medium containing 10% FCS, 100 units/mL penicillin, and 100 μg/mL streptomycin. 420
Gene expression 421
Relative mRNA abundance was determined using an Applied Biosystems 7500 or 7900HT 422 instrument and PowerUp SYBR Green Master Mix (Thermo Fisher Scientific Cat# A25742). 423
Fold-change mRNA expression was calculated versus Ppia by using the 2 -ΔΔCt method. For 424 primer sequences, see the Resource Table. 425
Glucagon and insulin assays 426
Batches of 10 islets were pre-incubated in either 10 mM or 3 mM glucose for 1 hour at 37°C 427 in buffer containing (in mmol/L) 120 NaCl, 4.8 KCl, 24 NaHCO 3 , 0.5 Na 2 HPO 4 , 5 HEPES, 2.5 428
CaCl 2 , 1.2 MgCl 2 , and 3-17 D-glucose + 0.1% BSA. For glucagon secretion, islets were 429 incubated in 10 mM, 0.5 mM or 0.5 mM glucose + 5 μm epinephrine for 1 hour at 37°C. 430
Glucagon and insulin secreted into the supernatant was measured using specific 431 ultrasensitive HTRF assay (glucagon; Cisbio Cat# 62CGLPEG) (insulin; Cisbio Cat# 432 62IN2PEG). Total glucagon was measured from islets lysed in acid ethanol. Insulin was 433 measured similarly, but using batches of 10 islets sequentially incubated in 3 mM glucose, 434
17 mM glucose and 17 mM glucose + 10 mM KCl for 30 minutes at 37°C. In all cases, 435
values are normalized against total glucagon/insulin for each individual experiment to 436 account for differences in α-cell/β-cell proportion with treatment and islet size (Henquin, 437 2019). 438
Immunostaining of mouse tissue 439
Pancreata were fixed in 10% formalin overnight, before dehydration and wax embedding. 440
Sections were blocked with PBS-T + 1% BSA for 1 hour and incubated with primary 441
antibodies overnight at 4°C. Following washing in PBS-T + 0.1% BSA, secondary antibodies 442
were applied for 2 hours at room temperature. Primary antibodies were rabbit anti-insulin Images were captured using either Zeiss LSM780 or LSM880 meta-confocal microscopes, 464 the latter equipped with an Airyscan super-resolution module. Excitation was delivered at λ = 465 488 nm, λ = 568 and λ = 633 nm for Alexa Fluor 488, Alexa Fluor 568 and Alexa Fluor 633, 466
respectively. Emitted signals were detected using a GaAsP PMT detector at λ = 498-559, 467 nm λ = 568-629 and λ = 633-735 nm for Alexa Fluor 488, Alexa Fluor 568 and Alexa Fluor 468 633, respectively. Super-resolution images were subjected to online deconvolution 469 processing using Zen Black (Zeiss Microscopy). 470
Immunostaining of human tissue 471
Tissue was obtained from individuals with T1D and their age-matched controls. Donor 472 details are provided in Table S1 . Samples were dewaxed and rehydrated before antigen 473 retrieval and blocking with 5% normal goat serum. Primary antibodies were guinea pig anti- 
Analysis of α-cell and β-cell mass 488
Pancreatic sections for determination of α-cell and β-cell mass were stained as above, 489 before scanning and digitization using a Zeiss Axio Scan.Z1. Excitation was delivered at λ = 490 453-485 nm and λ = 590-650 nm for Alexa Fluor 488 and Alexa Fluor 647, respectively. 491
Emitted signals were detected using an Orca Flash 4.0 at λ = 507-546 nm and λ = 663-738 492 nm for Alexa Fluor 488 and Alexa Fluor 647, respectively. Overall 408 separate images were 493 captured for each pancreas section using a 20 x / 0.8 NA objective, before compilation into a 494 single image using Zen lite 2012. 495
Ca 2+ imaging 496
Islets were loaded with Fura2 (HelloBio HB0780-1mg) before imaging using a Crest X-Light 497
spinning disk system coupled to a Nikon Ti-E base and 10 x / 0.4 air objective. Excitation 498 was delivered at λ = 340 nm and λ = 385 nm using a FuraLED system, with emitted signals 499 detected at λ = 470-550 nm. Traces were presented as the emission ratio at 340 nm and 500 385 nm (i.e. 340/385). HEPES-bicarbonate buffer was used, containing (in mmol/L) 120 501
NaCl, 4.8 KCl, 24 NaHCO 3 , 0.5 Na 2 HPO 4 , 5 HEPES, 2.5 CaCl 2 , 1.2 MgCl 2 , and 0.5-17 D-502
glucose. 503
Electrophysiology 504
Whole-cell currents were recorded in intact islets using the standard whole-cell 505 configuration, as previously described (Briant et al., 2018) . Measurements were performed 506
using an EPC-10 patch-clamp amplifier and Patchmaster software (HEKA Electronics). 507
Currents were filtered at 2.9 kHz and digitized at more than 10 kHz. Currents were 508 compensated for capacitive transients and leak current subtraction was conducted. The 509 extracellular solution consisted of (in mM) 138 NaCl, 5.6 KCl, 1.2 MgCl 2 , 5 HEPES (pH 7.4 510 with NaOH), 2.6 CaCl 2 and 1 D-glucose. The intracellular solution contained (mM) 125 KCl, 511
1 CaCl 2 , 1 MgCl 2 , 5 HEPES, 3 MgATP and 10 EGTA (KOH buffered). All chemicals were 512
from Sigma-Aldrich UK. Recordings with an access resistance of < 50 mΩ were used for 513 analysis in MATLAB. The logistic regression model identifying cell type was implemented in 514 MATLAB as previously described (Briant et al., 2017a) . 515
QUANTIFICATION AND STATISTICAL ANALYSIS 516
Correlation analysis 517
Correlation analysis was performed using matrix binarization analyses (Hodson et al., 2012) . 518
Intensity over time traces were smoothed using Hilbert-Huang empirical mode 519 decomposition, and a 20% threshold used to binarize cells according to activity status. Co-520
activity was assessed using the equation
and T j is the period spent ON for each cell, and T ij is the period both cells spend on together. 522
Significance (P<0.01) was calculated versus the randomized dataset using a permutation 523 step based. Highly connected cells were identified based on their position (60-100% range) 524
within a probability-distribution, before construction of functional connectivity using link 525 number and Euclidean coordinates. 526
Image analysis 527
F-actin, G-actin and DBP expression levels were analyzed using integrated density (area x 528 mean fluorescence intensity), which accounts for the influence of cell size on fluorophore 529 emission intensity for a given pixel (i.e. intensity of n fluorescent molecules will increase as a 530 function of area -1 ). Corrected total cell fluorescence (CTCF) was then calculated as follows: 531
integrated density -(area of selected cell x mean background fluorescence) (Gavet and 532
Pines, 2010). Quantification of α-cell, β-cell and δ-cell area and number was performed on 533 binarized images using ImageJ (NIH) and Threshold, Nucleus Counter and Particle Analysis 534 plugins. 535
Glucagon granule distribution was analyzed using the G-function, which measures the 536 distance from any position to the nearest object of interest compared to a random 537 distribution of the same measured objects (FIJI Spatial Statistic 2D/3D plugin) (Zimmer et  538 al., 2010). A left shift away from the mean +/-95% confidence intervals indicates a less 539 random or more clustered organization. 540
Linear adjustments to brightness and contrast were applied to representative images, with 541
intensity values maintained between samples to allow accurate cross-comparison. For 542
super-resolution images, the following FIJI look-up-tables were used: NanoJ-Orange, cyan 543 and magenta. 544
Statistical analysis 545
Data normality was assessed using D'Agostino-Person test. Unpaired/paired Students t-test 546
or Mann-Whitney test were used for pairwise comparisons. Multiple interactions were 547 determined using one-way or two-way ANOVA followed by Tukey's, Dunnett's, Bonferonni's 548 or Sidak's post-hoc tests (accounting for degrees of freedom). Analyses were conducted 549
using GraphPad Prism or Excel software 550
Data availability 551
The datasets generated and/or analyzed during the current study are available from the 552 corresponding author upon reasonable request. 553 resembling an α-cell or δ-cell, respectively, in DBP -/islets (n = 17-22 cells, 3 animals) 823
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(Mann-Whitney test). 824 (Q) α-cell capacitance is significantly reduced in DBP -/islets (n = 17-22 cells, 3 animals) 825
(unpaired t-test). 826 (R) Glucagon secretion is impaired in DBP -/islets in response to low (0.5 mM) glucose and 827 low (0.5 mM) glucose + epinephrine (data are shown normalized to content or as fold-828 change) (n = 13-14 replicates, 10 animals) (two-way ANOVA with Bonferroni's multiple 829
comparisons test, or unpaired t-test). 830 (S) Glucagon content is similar in DBP +/+ and DBP -/islets (n = 12 replicates, 8 animals) 831
(unpaired t-test). 
